Welte A

Key issues in the clinical development and implementation of TB vaccines in South Africa
Rustomjee R, Mcleod R, Hanekom W, Steel G, Mahomed H, Hawkridge A, Welte A, Sinanovic E, Loots G, Grobler A, Mvusi L, Gray G, Hesseling AC, Ginsberg A, Lienhardt C, Shea J, Tong X, Lockhart S, Churchyard GJ

Tuberculosis

(2012)

https://doi.org/10.1016/j.tube.2012.05.001
A general HIV incidence inference scheme based on likelihood of individual level data and a population renewal equation
Mahiane GS, Ouifki R, Brand H, Delva W, Welte A

PLoS One

(2012)

https://doi.org/10.1371/journal.pone.0044377
HIV treatment as prevention: models, data, and questions–towards evidence-based decision-making
Bärnighausen T, Delva W, Welte A, Williams BG, HIV Modelling Consortium Treatment as Prevention Editorial Writing Group, et al

PLoS Medicine

(2012)

https://doi.org/10.1371/journal.pmed.1001259
HIV treatment as prevention: principles of good HIV epidemiology modelling for public health decision-making in all modes of prevention and evaluation
Delva W, Abu-Raddad LJ, Gorgens M, Wilson D, Hallett TB, Welte A

PLoS Medicine

(2012)

https://doi.org/10.1371/journal.pmed.1001239
Workshop summary: Novel biomarkers for HIV incidence assay development
Shapiro S, McMichael R, Burns DN, Welte A, Sharma UK, Schito M, Rousseau C, Fitzgibbon J, Keele B

AIDS Research And Human Retroviruses

(2012)

https://doi.org/10.1089/aid.2011.0332
Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa
Osman M, Meehan S, Von Delft A, Du Preez K, Dunbar R, Marx FM, Boulle A, Welte A, Naidoo P, Hesseling AC

PLOS ONE

(2021)

https://doi.org/10.1371/Journal.pone.0252084
Towards eliminating bias in cluster analysis of TB genotyped data
van Schalkwyk C, Cule M, Welte A, van Helden PD, van der Spuy G, Uys P

PLoS ONE

(2012)

https://doi.org/10.1371/journal.pone.0034109
Age-disparate relationships and implications for STI transmission among young adults in Cape Town, South Africa
Beauclair RN, Kassanjee R, Temmerman M, Welte A, Delva W

The European Journal Of Contraception and Reproductive Health Care

(2012)

https://doi.org/10.3109/13625187.2011.644841
Sexual risk behaviors among HIV-infected South African men and women with their partners in a primary care program: implications for couples-based prevention
Venkatesh KK, de Bruyn G, Lurie MN, Modisenyane T, Triche EW, Gray GE, Welte A, Martinson NA

AIDS Behavior

(2012)

https://doi.org/10.1007/s10461-011-9941-y
Tuberculosis in a South African prison – a transmission modelling analysis
Johnstone-Robertson S, Lawn SD, Welte A, Bekker LG, Wood R

South African Medical Journal

(2011)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538692/
Age-disparity, sexual connectedness and HIV infection in disadvantaged communities around Cape Town, South Africa: a study protocol
Delva W, Beauclair RN, Welte A, Vansteelandt S, Hens N, Aerts M, Du Toit E, Beyers N, Temmerman M

BMC Public Health

(2011)

https://doi.org/10.1186/1471-2458-11-616
Treatment-centred prevention: an integrated biomedical and social approach to HIV prevention
Delva W, Verguet S, Hargrove JW, Williams BG, Sheneberger R, Stander T, Welte A

AIDS

(2011)

https://doi.org/10.1097/QAD.0b013e3283488503
Treatment as prevention: preparing the way
Williams BG, Wood R, Dukay V, Delva W, Ginsburg D, Hargrove JW, Stander M, Sheneberger R, Montaner J, Welte A

Journal of the International AIDS Society

(2011)

https://doi.org/10.1186/1758-2652-14-S1-S6
Modelling the impact of acute infection dynamics on the accumulation of HIV-1 mutations
Shiri T, Welte A

Journal of Theoretical Biology

(2024)

https://doi.org/10.1016/j.jtbi.2011.03.011
How different are the costs and consequences of delayed versus immediate HIV treatment?
Welte A, Hargrove JW, Delva W, Williams BG, Stander T

South African Medical Journal

(2011)

http://www.samj.org.za/index.php/samj/article/viewFile/4700/3235
Seroconverting blood donors as a resource for characterising and optimising recent infection testing algorithms for incidence estimation
Kassanjee R, Welte A, Busch MP, McWalter TA, Keating SM, Vermeulen M, Stramer SL

PLoS One

(2011)

https://doi.org/10.1371/journal.pone.0020027
Is it possible to decrease the incidence of peri-operative stroke associated with acute peri-operative beta-blocker administration?
Biccard BM, Kassanjee R, Welte A

Anaesthesia

(2011)

https://doi.org/10.1111/j.1365-2044.2010.06614.x
HIV incidence estimation using the BED capture enzyme immunoassay
Bärnighausen T, McWalter TA, Rosner Z, Newell ML, Welte A

Epidemiology

(2010)

https://doi.org/10.1097/ede.0b013e3181e9e978
Using tests for recent infection to estimate incidence: problems and prospects for HIV
Welte A, McWalter TA, Hallett TB, Laeyendecker O

Eurosurveillance

(2010)

https://doi.org/10.2807/ese.15.24.19589-en
Relating recent infection prevalence to incidence with a sub-population of assay non-progressors
Welte A, McWalter TA

Journal of Mathematical Biology

(2010)

https://doi.org/10.1007/s00285-009-0282-7
Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy
Humphrey JH, Hargrove JW, Welte A, Marinda ET, Preiser W, Slabbert H, van Zyl G, Levin J, Moulton LH

Journal of Acquired Immune Deficiency Syndromes

(2010)

https://doi.org/10.1097/qai.0b013e3181b61938
Estimating HIV incidence in populations using tests for recent infection: issues, challenges and the way forward
Mastrorea TD, Kim A, Hallett TB, Rehle T, Welte A, Laeyendecker O, Oluoch T, Garcia Calleja JM

Journal of HIV/AIDS Surveillance and Epidemiology

(2010)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130510/
A comparison of biomarker based incidence estimators
Welte A, McWalter TA

PLoS One

(2009)

https://doi.org/10.1371/journal.pone.0007368
Reply to ?Should biomarker estimates of HIV incidence be adjusted?
Welte A, McWalter TA, Bärnighausen T

AIDS

(2009)

https://doi.org/10.1097/QAD.0b013e32832eff59
Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making?
Auvert B, Porco TC, Dorrington R, Schmid G, Hankins C, Stover J, Raddad LA, Weiss H, Bollinger L, White P, Ghani A, White RG, Gray R, Hallet TB, Hargrove JW, Kahn JG, Welte A, Lohse N, Williams BG, Nagelkerke N

PLoS Medicine

(2009)

https://doi.org/10.1371/journal.pmed.1000109

Previous 234 Next

Welte A

Key issues in the clinical development and implementation of TB vaccines in South Africa

A general HIV incidence inference scheme based on likelihood of individual level data and a population renewal equation

HIV treatment as prevention: models, data, and questions–towards evidence-based decision-making

HIV treatment as prevention: principles of good HIV epidemiology modelling for public health decision-making in all modes of prevention and evaluation

Workshop summary: Novel biomarkers for HIV incidence assay development

Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa

Towards eliminating bias in cluster analysis of TB genotyped data

Age-disparate relationships and implications for STI transmission among young adults in Cape Town, South Africa

Sexual risk behaviors among HIV-infected South African men and women with their partners in a primary care program: implications for couples-based prevention

Tuberculosis in a South African prison – a transmission modelling analysis

Age-disparity, sexual connectedness and HIV infection in disadvantaged communities around Cape Town, South Africa: a study protocol

Treatment-centred prevention: an integrated biomedical and social approach to HIV prevention

Treatment as prevention: preparing the way

Modelling the impact of acute infection dynamics on the accumulation of HIV-1 mutations

How different are the costs and consequences of delayed versus immediate HIV treatment?

Seroconverting blood donors as a resource for characterising and optimising recent infection testing algorithms for incidence estimation

Is it possible to decrease the incidence of peri-operative stroke associated with acute peri-operative beta-blocker administration?

HIV incidence estimation using the BED capture enzyme immunoassay

Using tests for recent infection to estimate incidence: problems and prospects for HIV

Relating recent infection prevalence to incidence with a sub-population of assay non-progressors

Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy

Estimating HIV incidence in populations using tests for recent infection: issues, challenges and the way forward

A comparison of biomarker based incidence estimators

Reply to ?Should biomarker estimates of HIV incidence be adjusted?

Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making?

Type

Year

Author